Tony Rice, Chairman, sold 20,000 shares in the company on the 17th September 2019 at a price of 2909.97p. The Director now holds 20,000 shares....

Robyn Perriss, Financial Director, exercised 150,251 shares in the company on the 17th September 2019 at a price of 0.00p. The Director now holds 391,401...

Robyn Perriss, Financial Director, sold post-exercise 123,410 shares in the company on the 17th September 2019 at a price of 541.60p. The Director now holds...

Colin Rae, Non Executive Director, bought 20,000 shares in the company on the 17th September 2019 at a price of 110.00p. The Director now holds...

Peter Brooks-Johnson, Chief Executive Officer, exercised 776,260 shares in the company on the 17th September 2019 at a price of 0.00p. The Director now holds...

Peter Brooks-Johnson, Chief Executive Officer, sold post-exercise 533,200 shares in the company on the 17th September 2019 at a price of 541.60p. The Director now...

UBS today reaffirms its neutral investment rating on Travis Perkins PLC (LON:TPK) and raised its price target to 1380p (from 1350p).

Broker Forecasts data provided...

UBS today reaffirms its neutral investment rating on Spire Healthcare Group (LON:SPI) and cut its price target to 117p (from 120p).

Broker Forecasts data provided...

Salt Lake Potash said it had completed pilot plant test work of salts from its Lake Way potash development at the Saskatchewan Research Council.

The...